BACKGROUND: To optimize the management of patients with schizophrenia, quantification
of treatment effects is crucial. While in research studies, the use of quantitative assessments …

Efficacy studies fail to consider the multiple aspects of schizophrenia that determine the
overall clinical effectiveness of treatment. We address this shortcoming by proposing …

Introduction Prompt administration of antipsychotic treatment that is adhered to is essential
for the optimal treatment of schizophrenia. Many patients have benefited from the advent of …

Schizophrenia is a complex, heterogeneous, multidimensional disorder within which
negative symptoms are a significant and disabling feature. Whilst there is no established …

To advance effectiveness research in mental health, we need common, standardized,
validated instruments that can be used easily in routine practice settings. The Schizophrenia …

Affecting up to 1% of the global population, schizophrenia is a chronic, disabling psychiatric
disorder that has profound effects on patients, families, and caretakers due to its tremendous …

Abstract The Mental Health Centers for Intervention Development and Applied Research
(CIDAR) program prioritized research to provide an evidence base for biomarker …

OBJECTIVE: Many rating scales have been in use to evaluate various symptomatic
domains, and eventually there are too many scales to be selected and widely utilized in …

OBJECTIVES: Expectations in treating schizophrenia are expanding beyond just controlling
psychotic symptoms to include functional recovery. This report describes an approach to …

Outcome has been a key concern in schizophrenia since Kraepelin first identified the
disorder. The outcomes that researchers and clinicians use and value in their work with it …